A key goal for the first Vasalgel studies, in addition to demonstrating the contraceptive’s safety and effectiveness, was to establish its reversibility. Vasalgel was reversible

With a year of animal efficacy studies done on Vasalgel male contraceptive, we’ve demonstrated its feasibility — and it’s time to build momentum! But it

A LOT of men (and their partners) are waiting eagerly for news of the clinical trials of Vasalgel. It’s getting closer! Over the next six

World Vasectomy Day is an educational event to promote greater understanding and participation by men in family planning. A number of educational events took place on

A history of male contraceptive development – as experienced and related by our founder Elaine Lissner – was recently covered in a Priceonomics article called “The

The Telegraph announced that only one in 10 British men would take a male birth control pill when it is available. This finding is opposite

The topic of male contraception was covered in an article by Kristen Fawcett for US News and World Report. Vasalgel and Clean Sheets Pill were

Vasalgel has enjoyed significant media presence recently which is continuing into 2015. The Santa Fe Reporter highlighted the advancements that Vasalgel promises to bring to

Elaine Lissner, Director of Parsemus Foundation, was interviewed by ABC TV news – San Francisco. The piece focused on the development of Vasalgel and aired